Managing cognitive symptoms and fatigue in cholestatic liver disease
- PMID: 33131347
- DOI: 10.1080/17474124.2021.1844565
Managing cognitive symptoms and fatigue in cholestatic liver disease
Abstract
Introduction: Patients with cholestatic diseases may develop fatigue and cognitive symptoms. The impact of symptom burden may be significant in some patients. To date, there are no effective pharmacological therapies to improve cognitive symptoms or fatigue in cholestasis and we are wholly reliant on supportive approaches. Area covered: This review provides an overview of cognitive symptoms and fatigue in the cholestatic liver disease primary biliary cholangitis (PBC), including pathophysiology and our approach to the management of these symptoms. Expert opinion: The impact of fatigue and cognitive symptoms on the perceived quality of life can be profound for patients with PBC. The pathophysiology of these symptoms is complex and poorly understood, making the development of therapeutic trials of symptom-directed therapies challenging. The current recommended management for fatigue and cognitive symptoms is mainly supportive.
Keywords: Cognitive symptoms; central and peripheral fatigue; cholestasis; fatigue; primary biliary cholangitis.
Similar articles
-
Symptoms of PBC - Pathophysiology and management.Best Pract Res Clin Gastroenterol. 2018 Jun-Aug;34-35:41-47. doi: 10.1016/j.bpg.2018.06.007. Epub 2018 Jun 14. Best Pract Res Clin Gastroenterol. 2018. PMID: 30343709 Review.
-
Pruritus and fatigue in primary biliary cirrhosis.Clin Liver Dis. 2003 Nov;7(4):879-900. doi: 10.1016/s1089-3261(03)00105-3. Clin Liver Dis. 2003. PMID: 14594135 Review.
-
Management of symptom complexes in primary biliary cholangitis.Curr Opin Gastroenterol. 2016 May;32(3):204-9. doi: 10.1097/MOG.0000000000000254. Curr Opin Gastroenterol. 2016. PMID: 26825590 Review.
-
Understanding and Treating Fatigue in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.Clin Liver Dis. 2016 Feb;20(1):131-42. doi: 10.1016/j.cld.2015.08.007. Clin Liver Dis. 2016. PMID: 26593295 Review.
-
Review article: pathophysiology and management of primary biliary cholangitis.Aliment Pharmacol Ther. 2020 Oct;52(7):1150-1164. doi: 10.1111/apt.16023. Epub 2020 Aug 19. Aliment Pharmacol Ther. 2020. PMID: 32813299 Review.
Cited by
-
New IMB16-4 Hot-Melt Extrusion Preparation Improved Oral Bioavailability and Enhanced Anti-Cholestatic Effect on Rats.Drug Des Devel Ther. 2023 Feb 28;17:649-657. doi: 10.2147/DDDT.S395114. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 36879928 Free PMC article.
-
Guidelines for the Management of Cholestatic Liver Diseases (2021).J Clin Transl Hepatol. 2022 Aug 28;10(4):757-769. doi: 10.14218/JCTH.2022.00147. Epub 2022 Apr 29. J Clin Transl Hepatol. 2022. PMID: 36062287 Free PMC article.
-
Exploring the Potential Mechanisms of Action of Gentiana Veitchiorum Hemsl. Extract in the Treatment of Cholestasis using UPLC-MS/MS, Systematic Network Pharmacology, and Molecular Docking.Comb Chem High Throughput Screen. 2024;27(13):1948-1968. doi: 10.2174/0113862073275657231210055250. Comb Chem High Throughput Screen. 2024. PMID: 38357941
-
Is fatigue related to the severity of liver inflammation in patients with chronic liver disease? A cross-sectional study.BMJ Open. 2023 Apr 20;13(4):e069028. doi: 10.1136/bmjopen-2022-069028. BMJ Open. 2023. PMID: 37080620 Free PMC article.
-
Regulation of mild cognitive impairment associated with liver disease by humoral factors derived from the gastrointestinal tract and MRI research progress: a literature review.Front Neurosci. 2023 Jun 16;17:1206417. doi: 10.3389/fnins.2023.1206417. eCollection 2023. Front Neurosci. 2023. PMID: 37397455 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical